131 related articles for article (PubMed ID: 14611912)
21. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients.
Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K
Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344
[TBL] [Abstract][Full Text] [Related]
22. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.
Lee BE; von Haag D; Lown T; Lau D; Calhoun R; Follette D
J Thorac Cardiovasc Surg; 2007 Mar; 133(3):746-52. PubMed ID: 17320577
[TBL] [Abstract][Full Text] [Related]
23. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
24. Use of positron emission tomography in initial staging of nonsmall cell lung carcinoma: a regional teaching hospital experience.
Geraldson CT; Stephenson JE; Lagrew JP; Schammel CM; Schammel DP; Greene RA; Bolton WD
Am Surg; 2012 Mar; 78(3):305-8. PubMed ID: 22524768
[TBL] [Abstract][Full Text] [Related]
25. Mediastinal staging by videomediastinoscopy in clinical N1 non-small cell lung cancer: a prospective multicentre study.
Decaluwé H; Dooms C; D'Journo XB; Call S; Sanchez D; Haager B; Beelen R; Kara V; Klikovits T; Aigner C; Tournoy K; Zahin M; Moons J; Brioude G; Trujillo JC; Klepetko W; Turna A; Passlick B; Molins L; Rami-Porta R; Thomas P; Leyn P
Eur Respir J; 2017 Dec; 50(6):. PubMed ID: 29269579
[TBL] [Abstract][Full Text] [Related]
26. Improved radiologic staging of lung cancer with 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography and computed tomography registration.
Aquino SL; Asmuth JC; Alpert NM; Halpern EF; Fischman AJ
J Comput Assist Tomogr; 2003; 27(4):479-84. PubMed ID: 12886128
[TBL] [Abstract][Full Text] [Related]
27. Staging of lymph nodes with FDG dual-headed PET in patients with non-small-cell lung cancer.
Stokkel MP; Bakker PF; Heine R; Schlösser NJ; Lammers JW; Van Rijk PP
Nucl Med Commun; 1999 Nov; 20(11):1001-7. PubMed ID: 10572909
[TBL] [Abstract][Full Text] [Related]
28. The role of extended cervical mediastinoscopy in staging of non-small cell lung cancer of the left lung and a comparison with integrated positron emission tomography and computed tomography: does integrated positron emission tomography and computed tomography reduce the need for invasive procedures?
Metin M; Citak N; Sayar A; Pekcolaklar A; Melek H; Kök A; Gurses A
J Thorac Oncol; 2011 Oct; 6(10):1713-9. PubMed ID: 21716145
[TBL] [Abstract][Full Text] [Related]
29. Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer.
Yang W; Fu Z; Yu J; Yuan S; Zhang B; Li D; Xing L; Zhao D; Mu D; Sun X; Fang Y; Huang Y; Li W
Lung Cancer; 2008 Jul; 61(1):35-43. PubMed ID: 18177978
[TBL] [Abstract][Full Text] [Related]
30. Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer?
Kernstine KH; Mclaughlin KA; Menda Y; Rossi NP; Kahn DJ; Bushnell DL; Graham MM; Brown CK; Madsen MT
Ann Thorac Surg; 2002 Feb; 73(2):394-401; discussion 401-2. PubMed ID: 11845848
[TBL] [Abstract][Full Text] [Related]
31. PET-CT in presurgical lymph node staging in non-small cell lung cancer: the importance of false-negative and false-positive findings.
Bustos García de Castro A; Ferreirós Domínguez J; Delgado Bolton R; Fernández Pérez C; Cabeza Martínez B; García García-Esquinas M; Carreras Delgado JL
Radiologia; 2017; 59(2):147-158. PubMed ID: 28238444
[TBL] [Abstract][Full Text] [Related]
32. Improvement of non-small-cell lung cancer staging by means of positron emission tomography.
Albes JM; Lietzenmayer R; Schott U; Schülen E; Wehrmann M; Ziemer G
Thorac Cardiovasc Surg; 1999 Feb; 47(1):42-7. PubMed ID: 10218620
[TBL] [Abstract][Full Text] [Related]
33. Value of FDG PET in the management of NSCLC.
Ukena D; Hellwig D
Lung Cancer; 2004 Aug; 45 Suppl 2():S75-8. PubMed ID: 15552785
[TBL] [Abstract][Full Text] [Related]
34. Positron emission tomography may underestimate the extent of thoracic disease in lung cancer patients.
Carnochan FM; Walker WS
Eur J Cardiothorac Surg; 2009 May; 35(5):781-4; discussion 784-5. PubMed ID: 19272791
[TBL] [Abstract][Full Text] [Related]
35. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
Yang WF; Tan GZ; Fu Z; Yu JM
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335
[TBL] [Abstract][Full Text] [Related]
36. Pre- and intra-operative mediastinal staging in non-small-cell lung cancer.
Lardinois D
Swiss Med Wkly; 2011; 141():w13168. PubMed ID: 21384283
[TBL] [Abstract][Full Text] [Related]
37. [The role of positron emission tomography (PET) in mediastinal staging of non-small cell lung cancer].
Melek H; Günlüoğlu MZ; Demir A; Akin H; Medetoğlu B; Kara HV; Olçmen A; Dinçer SI
Tuberk Toraks; 2008; 56(1):56-63. PubMed ID: 18330756
[TBL] [Abstract][Full Text] [Related]
38. [Mediastinal lymph node staging in non-small cell lung cancer: comparison between spiral computed tomographic findings and pathology].
Zheng L; Wu PH; Mo YX; Xie CM; Ruan CM; Li L; Shen JX; Rong TH; Wang X; Zhang SY
Ai Zheng; 2006 Nov; 25(11):1384-8. PubMed ID: 17094906
[TBL] [Abstract][Full Text] [Related]
39. Does whole-body 2-[18F]-fluoro-2-deoxy-D-glucose positron emission tomography have an advantage over thoracic positron emission tomography for staging patients with lung cancer?
Aquino SL; Fischman AJ
Chest; 2004 Sep; 126(3):755-60. PubMed ID: 15364753
[TBL] [Abstract][Full Text] [Related]
40. Value of positron emission tomography for lung cancer staging.
Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
